This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Fabrinet (FN) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Here is how Fabrinet (FN) and Plexus (PLXS) have performed compared to their sector so far this year.
Intuit (INTU) Boosts NFL Partnership With Contract Renewal
by Zacks Equity Research
Under the latest contract renewal, Intuit (INTU) will serve as the official financial and accounting software sponsor of the NFL through 2026.
Palo Alto (PANW) Q1 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Palo Alto Networks' (PANW) fiscal Q1 results reflect benefits from solid demand across its cyber security portfolio amid the growing hybrid work trend and cloud migration worldwide.
Zacks Industry Outlook Highlights nVent Electric, Littelfuse and Fabrinet
by Zacks Equity Research
nVent Electric, Littelfuse and Fabrinet have been highlighted in this Industry Outlook article.
3 Electronics Stocks to Escape Pandemic-Led Disruptions
by Shilpa Mete
The Zacks Electronics - Miscellaneous Components industry players like NVT, LFUS and FN are set to gain from a solid adoption of AI and the democratization of IoT techniques.
Sabre (SABR) Teams Up With Trava to Scale Post-Booking Process
by Zacks Equity Research
Sabre (SABR) enters into a Premium Solution Partnership with Trava to digitalize the post-booking process of its travel agents with increased efficiency and enhanced end-user experiences.
Here is Why Growth Investors Should Buy Fabrinet (FN) Now
by Zacks Equity Research
Fabrinet (FN) possesses solid growth attributes, which could help it handily outperform the market.
Fabrinet (FN) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Fabrinet (FN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for November 16th
by Zacks Equity Research
ENTX, STIM, FN, ANGN and FUTU have been added to the Zacks Rank #1 (Strong Buy) List on November 16, 2022.
Infosys (INFY) BPM & IBM Launches Center of AI and Automation
by Zacks Equity Research
Infosys (INFY) opens the Center of AI and Automation in Poland, in collaboration with IBM to enhance the digital excellence of enterprise clients globally.
SAIC Secures Contract With U.S Army Enterprise Service Desk
by Zacks Equity Research
Per the latest contract from the U.S Army Enterprise Service Desk (AESD), Science Applications (SAIC) will continue to provide software development and management services to the armed force.
Micron (MU) Avails DDR5 Memory for 4G AMD EPYC Processors
by Zacks Equity Research
Micron (MU) makes DDR5 memory available for the latest 4th Generation EPYC 9004 Series processors from Advanced Micro Devices.
Don't Ignore These 3 Top-Ranked Stocks Pushing 52-Week Highs
by Derek Lewis
While the market continues to react to the CPI print, a few stocks have been quietly strong, pushing 52-week highs.
3D Systems (DDD) and ALM Team Up for Portfolio Expansion
by Zacks Equity Research
3D Systems (DDD) and ALM partner to expand additive manufacturing material portfolio, providing access to 3D Systems' new first-to-market solution, DuraForm PAx, which is a nylon copolymer material.
Amdocs' (DOX) Vubiquity Platform Selected by Israel's Cellcom
by Zacks Equity Research
Under the latest renewal contract, Amdocs (DOX) enhances the digital experiences of the viewers of Israel's Cellcom TV by providing them access to the best-in-class linear and video-on-demand content choices.
Is CSG Systems International (CSGS) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Here is how CSG Systems (CSGS) and Fabrinet (FN) have performed compared to their sector so far this year.
Fabrinet (FN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 13.22% and 3.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American Superconductor (AMSC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Superconductor (AMSC) delivered earnings and revenue surprises of -9.52% and 11.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Company News for Aug 17, 2022
by Zacks Equity Research
Companies In The News Are: FN, FLNC, SE, WWE.
Fabrinet (FN) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Fabrinet's (FN) fourth-quarter fiscal 2022 results reflect a positive impact from optical communications and datacom business. However, the negative impact of supply-chain pressures is a bane.
Fabrinet (FN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 8.39% and 1.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Fabrinet (FN) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Fabrinet's (FN) Q4 fiscal 2022 results are likely to reflect the negative impact of delayed customer programs due to requalification efforts and the rising supply-chain disruptions.
Meta Materials Inc. (MMAT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Meta Materials Inc. (MMAT) delivered earnings and revenue surprises of -40% and 8.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Novanta (NOVT) Moves 9.6% Higher: Will This Strength Last?
by Zacks Equity Research
Novanta (NOVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Fabrinet (FN) Moves 6% Higher: Will This Strength Last?
by Zacks Equity Research
Fabrinet (FN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.